Skip to main content

Emergency Care Updates

This page is intended for Healthcare Professionals Only

Unable to load Tweets

The Recovery Trial: Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

The findings of this well done randomized controlled trial indicate that in patients with COVID-19 pneumonia, that dexamethasone improves 28d mortality compared to placebo in patients requiring invasive mechanical ventilation (IMV) (NNT = 8.5) and those patients requiring oxygen therapy (NNT = 29).  There was no benefit to patients not requiring oxygenation support and even a signal for harm.  It is important to remember this is a preprint, preliminary report, which is better than a press release. At this time, in patients requiring any oxygen therapy, HFNC, NIV, IMV, or ECMO I would recommend dexamethasone until further evidence disproves this benefit.

COVID-19 Rx: Treatment Simulations

You are a health care provider in a developed country. Several patients await your care. These patients are suspected of having COVID-19 and have been triaged by severity of illness. We recommend starting with the mildly ill patient, but you are free to see them in any order.

1 2 138

Emergency Medicine

Emergency medicine is a field of practice based on the knowledge and skills required for the prevention, diagnosis and management of acute and urgent aspects of illness and injury affecting patients of all age groups with a full spectrum of episodic undifferentiated physical and behavioural disorders (IFEM) - WATCH VIDEO

Emergency Topics

previous arrow
next arrow
Slider

Get notified everytime there is a new post

Enter your email address below to receive notifications of new posts by email.

Follow us everywhere